Legend Biotech (LEGN) Assets Average (2020 - 2025)

Legend Biotech has reported Assets Average for 6 years, with the latest figure at $1.7 billion in Q4 2025.

• For the quarter ending Q4 2025, Assets Average rose 1.19% year-over-year to $1.7 billion; the trailing twelve-month figure through Dec 2025 stood at $1.7 billion (up 1.19% YoY), and the FY2025 full-year result was $1.7 billion, down 3.27% from the prior year.
• Assets Average for Q4 2025 stood at $1.7 billion, up from $1.7 billion in the prior quarter.
• The five-year high for Assets Average was $745.2 billion in Q2 2021, with the low at $966.6 million in Q4 2021.
• Historically, Assets Average has averaged $89.0 billion across 5 years, with a median of $1.7 billion in 2025.
• Annual changes were most pronounced in 2021 — Assets Average tumbled 99.73% — and 2024, when it soared 42.65%.
• Legend Biotech's Assets Average stood at $966.6 million in 2021, then increased by 11.92% to $1.1 billion in 2022, then surged by 70.45% to $1.8 billion in 2023, then retreated by 7.64% to $1.7 billion in 2024, then climbed by 1.19% to $1.7 billion in 2025.
• The last three Assets Average figures came in at $1.7 billion (Q4 2025), $1.7 billion (Q3 2025), and $1.7 billion (Q2 2025), per Business Quant data.